Overview
Primary Objectives:
* To determine the acute and long-term outcomes of redo TAVR for the treatment of BVF affecting TAVs
* To determine the factors which are associated with the acute and long-term outcomes of redo TAVR
Principal investigator
Eligibility criteria
Inclusion Criteria:
* BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR
Exclusion Criteria:
* BVF due solely to paravalvular regurgitation
* Active endocarditis
* Untreated acute valve thrombosis
* Life-expectancy less than 1-year
* Subject is less than legal age of consent, legally incompetent, or otherwise vulnerable
* Participating in another study that may influence the outcome of this study
* BVF of a TAV (either Medtronic or Edwards) requiring redo TAVR
Exclusion Criteria:
* BVF due solely to paravalvular regurgitation
* Active endocarditis
* Untreated acute valve thrombosis
* Life-expectancy less than 1-year
* Subject is less than legal age of consent, legally incompetent, or otherwise vulnerable
* Participating in another study that may influence the outcome of this study
For Referring Providers
Do you have a patient you think would be a good candidate for this trial? Learn more about enrolling your patient.